Recombinant DNA Advisory Committee- 9/12-13/94 
Igor Gonda, Genentech, Inc. 
Christine Gorman, Time Magazine 
Angus Grant, Food and Drug Administration 
Tina Grasso, GenVec, Inc. 
Nicolaas Groot, The Netherlands Health Department 
Mariann Grossman, University of Pennsylvania 
Bill Guggino, Johns Hopkins University 
Jeff Gustavson, Act Up, Goldengate 
Paul Hallenbeck, Genetic Therapy, Inc. 
Jacqueline Hampton, Weinberg Consulting Group 
Elie Hanania, MD Anderson Cancer Center 
Rebecca Harmon, University of Pennsylvania 
Jeffrey Holt, Vanderbilt University 
Joseph Hughes, Quality Biotech 
Edie Irvine, Genetic Therapy, Inc. 
Jeffrey Isner, St. Elizabeth’s Medical Center 
John Jaugstetter, Genentech, Inc. 
Alice Johnson, Virginia Breast Cancer Foundation 
Susan Jones, Virus Research Institute 
Larry Kaiser, University of Pennsylvania 
Katherine Kaufmann, GenVec, Inc. 
Connie Kirby, Canji, Inc. 
Steve Kradjian, Vical, Inc. 
Toshi Kotani, Genetic Therapy, Inc. 
Imre Kovesdi, GenVec, Inc. 
Alex Kuta, Food and Drug Administration 
Eugene LaBrec, E.H. LaBrec & Associates 
Jane Lebkowski, Applied Immune Sciences, Inc. 
David Levitt, University of Maryland 
Charles Link, Iowa Methodist University 
H. Kim Lyerly, Duke University 
Gail Maderis, Genzyme Corporation 
Tamie Malaska, Targeted Genetics Corporation 
Dan Maneval, Canji, Inc. 
Phillip Maples, Baxter Healthcare Corporation 
Tony Marcel, TMC Development 
Stephen Marcus, Genetic Therapy, Inc. 
Michael McCaughan, FDC Reports 
Gerard McGarrity, Genetic Therapy, Inc. 
R. Scott Mclvor, University of Minnesota 
Bruce Merchant, Viagene, Inc. 
Andra Miller, Food and Drug Administration 
Ron Morales, Harvard University 
Richard Moscicki, Genzyme Corporation 
Philip Noguchi, Food and Drug Administration 
Sheryl Osborne, Viagene, Inc. 
[14] 
Recombinant DNA Research, Volume 20 
